Tudorza Pressair Approved for COPD
TUESDAY, July 24 (Healthday News) -- The Tudorza Pressair (aclidinium bromide) inhaler has been approved by the U.S. Food and Drug Administration to treat narrowing of the lung airways associated with chronic obstructive pulmonary disease (COPD) in people 18 and older. read more..
source:http://yhoo.it/MHDHI3
No comments:
Post a Comment